STOCK TITAN

Hims & Hers Insider Sale Notice: 65,110 Class A Shares via Fidelity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) filing a Form 144 notifies the proposed sale of 65,110 Class A shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $3,292,903.57. The shares were acquired by restricted stock vesting on 09/15/2025 and paid as compensation. The filing also lists multiple Class A sales by Andrew Dudum and the Dudum Family Trust during the past three months, including sizable single-month transactions on 07/21/2025, 08/18/2025 and 09/16/2025. The filer certifies they are not aware of any undisclosed material adverse information and provides broker details and seller addresses as required by Rule 144.

Positive

  • Transparent disclosure of proposed sale details including broker, sale date, share count, and aggregate market value
  • Acquisition source clearly stated as restricted stock vesting and payment as compensation
  • Complete sale history for the past three months provided for the relevant sellers

Negative

  • Multiple large insider sales listed in the past three months, including transactions of 125,335 and 128,127 shares
  • Proposed sale represents a non-trivial market value ($3,292,903.57) that could increase available float when executed

Insights

TL;DR: Officer-related restricted shares vested and are being sold; several large recent dispositions are disclosed, which could affect float near-term.

The filing shows a 65,110-share proposed sale tied to restricted stock vesting and compensation, executed through Fidelity on 09/17/2025. The schedule of recent transactions reveals multiple substantial disposals by Andrew Dudum and an affiliated trust across June–September 2025, including transactions of 125,335 and 128,127 shares. For investors, these disclosures clarify insider liquidity and timing but do not include company operational metrics or forward guidance.

TL;DR: The Form 144 complies with Rule 144 disclosure requirements and documents insider sales tied to compensation vesting.

The notice specifies the relationship to the issuer through compensatory restricted stock vesting and contains the signature representation regarding material nonpublic information. It lists broker and seller contact details and shows aggregation of prior sales by the same parties. The filing provides the standard legal attestation and transaction chronology necessary for transparent insider sale reporting.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What Class A shares does the HIMS Form 144 propose to sell?

The notice proposes to sell 65,110 Class A shares through Fidelity Brokerage Services on 09/17/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired via restricted stock vesting on 09/15/2025 and the payment is listed as compensation.

What is the aggregate market value of the proposed sale?

The filing reports an aggregate market value of $3,292,903.57 for the 65,110 shares.

Does the Form 144 disclose recent insider sales for HIMS?

Yes; it lists multiple Class A sales by Andrew Dudum and the Dudum Family Trust during Jun–Sep 2025, with individual transactions including 125,335 and 128,127 shares.

Through which broker will the sale be executed?

The sale is to be executed through Fidelity Brokerage Services LLC at the address shown in the filing.